Intraductal tubular carcinoma of the pancreas: Case report with molecular analysis

Pancreas

Volumn 38, Issue 2, 2009, Pages 235-237

  Furukawa, Toru ^a   Hatori, Takashi ^a   Fukuda, Akira ^a   Fujita, Izumi ^a   Yamamoto, Masakazu ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; AMYLASE; BETA CATENIN; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; MUCIN 6; PROTEIN P53; KRAS PROTEIN, HUMAN; MUC5AC PROTEIN, HUMAN; MUC6 PROTEIN, HUMAN; MUCIN 5AC; ONCOPROTEIN; RAS PROTEIN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; AMYLASE BLOOD LEVEL; CASE REPORT; CONSERVATIVE TREATMENT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; HYPERAMYLASEMIA; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LETTER; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PANCREAS CARCINOMA; PANCREAS DUCT STENOSIS; PANCREAS RESECTION; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; ADENOCARCINOMA; CHEMISTRY; GENETICS; MUTATION; PANCREAS TUMOR; PATHOLOGY;

ADENOCARCINOMA; ADULT; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MUCIN 5AC; MUCIN-6; MUTATION; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SMAD4 PROTEIN;

EID: 65349091916     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318175e3e0     Document Type: Letter

References (10)

1. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977-987.
2. Hruban RH, Pitman MB, Klimstra DS. In: Silverberg SG, ed. Tumors of the Pancreas. Washington, DC: American Registry of Pathology; 2007.
3. Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794-799.
4. Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 1994;425: 357-367.
5. Basturk O, Zamboni G, Klimstra DS, et al. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms. Am J Surg Pathol. 2007;31:363-370.
6. Tajiri T, Tate G, Kunimura T, et al. Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary-mucinous carcinoma, and ductal adenocarcinoma of the pancreas. Pancreas. 2004;29:116-122.
7. Nakayama Y, Inoue H, Hamada Y, et al. Intraductal tubular adenoma of the pancreas, pyloric gland type: a clinicopathologic and immunohistochemical study of 6 cases. Am J Surg Pathol. 2005;29:607-616.
8. Calhoun ES, Jones JB, Ashfaq R, et al. BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. Am J Pathol. 2003;163:1255-1260.
9. Hoorens A, Lemoine NR, McLellan E, et al. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol. 1993;143: 685-698.
10. Furukawa T, Fujisaki R, Yoshida Y, et al. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas. Mod Pathol. 2005;18: 1034-1042.